EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MYC inhibition by Omomyc causes DNA damage and overcomes PARPi resistance in breast cancer

Fabio Giuntini, Íñigo González-Larreategui, Andrea Herencia-Ropero, Silvia Casacuberta-Serra, Mariano F Zacarías-Fluck, Magdalena Arnal, Flaminia Pedretti, Sandra Martínez-Martín, Hugo Thabussot, Virginia Castillo Cano, Judit Grueso, Laia Foradada und 15 weitere

Cell Reports · 2025-12 · 44 (12) · 116604

DOI: 10.1016/j.celrep.2025.116604 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025-12. Verfasst von Fabio Giuntini und 26 weiteren Autor:innen. Beteiligte Einrichtung: Models of Cancer Therapies Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerase Inhibitors, DNA Damage, Proto-Oncogene Proteins c-myc, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Government of Catalonia, Agència de Gestió d'Ajuts Universitaris i de Recerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poly(ADP-ribose) Polymerase InhibitorsDNA DamageProto-Oncogene Proteins c-mycDrug Resistance, NeoplasmTriple Negative Breast NeoplasmsHumansFemaleCell Line, TumorAnimalsMiceDNA Repair

Stichwörter der Autor:innen

CP: cancerDNA damageOmomycPARPiTNBCtherapy resistance

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsProto-Oncogene Proteins c-mycMYC protein, human

Autor:innen und Institutionen

  • Models of Cancer Therapies Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Experimental Therapeutics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Peptomyc S.L., Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Models of Cancer Therapies Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Peptomyc S.L., Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Translational Genomics and Targeted Therapeutics in Solid Tumors, IDIBAPS, Barcelona, Spain.
  • Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Förderung

  • European Research Council
  • Government of Catalonia
  • Agència de Gestió d'Ajuts Universitaris i de Recerca
  • Carlos III Health Institute
  • Gobierno de España Ministerio de Ciencia e Innovación
  • European Commission
  • Fundación Cellex
  • H2020 European Research Council

Zitieren

APA

Giuntini, F., González-Larreategui, Í., Herencia-Ropero, A., Casacuberta-Serra, S., Zacarías-Fluck, M. F., Arnal, M., Pedretti, F., Martínez-Martín, S., Thabussot, H., Cano, V. C., Grueso, J., Foradada, L., Serrano, E., López-Estévez, S., Rodriguez, O., Guzman, M., Rodriguez-Hernandez, A., Brasó-Maristany, F., Llop-Guevara, A., …, & Soucek, L. (2025). MYC inhibition by Omomyc causes DNA damage and overcomes PARPi resistance in breast cancer. Cell Reports, 44(12), 116604. https://doi.org/10.1016/j.celrep.2025.116604

Vancouver

Giuntini F, González-Larreategui Í, Herencia-Ropero A, Casacuberta-Serra S, Zacarías-Fluck MF, Arnal M, et al. MYC inhibition by Omomyc causes DNA damage and overcomes PARPi resistance in breast cancer. Cell Reports. 2025;44(12):116604. doi:10.1016/j.celrep.2025.116604

BibTeX
@article{Giuntini2025,
  author = {Giuntini, Fabio and González-Larreategui, Íñigo and Herencia-Ropero, Andrea and Casacuberta-Serra, Silvia and Zacarías-Fluck, Mariano F and Arnal, Magdalena and Pedretti, Flaminia and Martínez-Martín, Sandra and Thabussot, Hugo and Cano, Virginia Castillo and Grueso, Judit and Foradada, Laia and Serrano, Erika and López-Estévez, Sergio and Rodriguez, Olga and Guzman, Marta and Rodriguez-Hernandez, Adela and Brasó-Maristany, Fara and Llop-Guevara, Alba and Balmaña, Judith and Nonell, Lara and Prat, Aleix and Serra, Violeta and Beaulieu, Marie-Eve and Whitfield, Jonathan R and Massó-Vallés, Daniel and Soucek, Laura},
  title = {MYC inhibition by Omomyc causes DNA damage and overcomes PARPi resistance in breast cancer},
  journal = {Cell Reports},
  year = {2025},
  volume = {44},
  number = {12},
  pages = {116604},
  doi = {10.1016/j.celrep.2025.116604}
}
Kostenlos starten →